Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study
ABSTRACT The aim of this single-center, retrospective observational study was to evaluate the effects of having a prosthetic implant (PI) and of changing from intravenous to oral antibiotics (oral stepdown therapy [OST]) on the risk of relapse in patients with otherwise uncomplicated Staphylococcus...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-07-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03337-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422788055531520 |
|---|---|
| author | Damien Blez Luc Labarbe Patrick Grohs Jean-Luc Mainardi Jean-Philippe Barnier David Lebeaux Marie Dubert |
| author_facet | Damien Blez Luc Labarbe Patrick Grohs Jean-Luc Mainardi Jean-Philippe Barnier David Lebeaux Marie Dubert |
| author_sort | Damien Blez |
| collection | DOAJ |
| description | ABSTRACT The aim of this single-center, retrospective observational study was to evaluate the effects of having a prosthetic implant (PI) and of changing from intravenous to oral antibiotics (oral stepdown therapy [OST]) on the risk of relapse in patients with otherwise uncomplicated Staphylococcus aureus bacteremia (SAB) treated with antibiotics for 14 days. The primary outcome was the 90-day SAB relapse rate in patients with and without a PI. Secondary outcomes were 90-day mortality among patients with or without a PI and 90-day SAB relapse and mortality in patients who had OST. We included 188 consecutive patients with SAB without metastatic foci and with a planned antibiotic treatment duration of 14 days: 58 (31%) had a presumed uninfected PI, and 108 (57%) had OST. Four patients (2%) relapsed, and 25 patients (13%) died. Patients with a PI were more likely to have diagnostic tests performed. In the univariate analysis, the presence of a PI (odds ratio [OR] 7 [95% confidence interval {CI} 0.9–144.0]) and OST (OR 0.7 [95% CI 0.1–6.2]) were not associated with 90-day relapse. In the multivariable analysis, the presence of a PI (adjusted odds ratio [aOR] 1.3 [95% CI 0.5–3.7]) and OST (aOR 0.5 [95% CI 0.2–1.4]) were not predictive of 90-day mortality. In a setting where full diagnostic workup and close follow-up can be ensured, the presence of a PI and OST did not seem to be associated with an increase in 90-day mortality in patients with otherwise uncomplicated SAB. Although the relapse rate was low overall, there was a non-significant trend toward a higher risk of relapse in patients with a PI.IMPORTANCEThis retrospective study provides reassuring real-world data supporting a short 14-day treatment course for SAB in patients with PIs. In an era of increasing antimicrobial resistance worldwide, these retrospective findings support the perspective that not all PIs are systematically infected. Prolonged antibiotic therapy may therefore not be routinely needed if infection is excluded and thorough evaluation for dissemination performed, accompanied by close clinical and biological monitoring. Early transition to oral therapy in this context, which has been implemented in our institution for years, does not appear to be associated with a higher risk of therapeutic failure. These findings align with the most recent literature on the subject. |
| format | Article |
| id | doaj-art-1a9ccd30003e4d5cbdd6b760d25e2002 |
| institution | Kabale University |
| issn | 2165-0497 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | Microbiology Spectrum |
| spelling | doaj-art-1a9ccd30003e4d5cbdd6b760d25e20022025-08-20T03:30:56ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-07-0113710.1128/spectrum.03337-24Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort studyDamien Blez0Luc Labarbe1Patrick Grohs2Jean-Luc Mainardi3Jean-Philippe Barnier4David Lebeaux5Marie Dubert6Service de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceService de Microbiologie, Unité Mobile d’Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, Île-de-France, FranceABSTRACT The aim of this single-center, retrospective observational study was to evaluate the effects of having a prosthetic implant (PI) and of changing from intravenous to oral antibiotics (oral stepdown therapy [OST]) on the risk of relapse in patients with otherwise uncomplicated Staphylococcus aureus bacteremia (SAB) treated with antibiotics for 14 days. The primary outcome was the 90-day SAB relapse rate in patients with and without a PI. Secondary outcomes were 90-day mortality among patients with or without a PI and 90-day SAB relapse and mortality in patients who had OST. We included 188 consecutive patients with SAB without metastatic foci and with a planned antibiotic treatment duration of 14 days: 58 (31%) had a presumed uninfected PI, and 108 (57%) had OST. Four patients (2%) relapsed, and 25 patients (13%) died. Patients with a PI were more likely to have diagnostic tests performed. In the univariate analysis, the presence of a PI (odds ratio [OR] 7 [95% confidence interval {CI} 0.9–144.0]) and OST (OR 0.7 [95% CI 0.1–6.2]) were not associated with 90-day relapse. In the multivariable analysis, the presence of a PI (adjusted odds ratio [aOR] 1.3 [95% CI 0.5–3.7]) and OST (aOR 0.5 [95% CI 0.2–1.4]) were not predictive of 90-day mortality. In a setting where full diagnostic workup and close follow-up can be ensured, the presence of a PI and OST did not seem to be associated with an increase in 90-day mortality in patients with otherwise uncomplicated SAB. Although the relapse rate was low overall, there was a non-significant trend toward a higher risk of relapse in patients with a PI.IMPORTANCEThis retrospective study provides reassuring real-world data supporting a short 14-day treatment course for SAB in patients with PIs. In an era of increasing antimicrobial resistance worldwide, these retrospective findings support the perspective that not all PIs are systematically infected. Prolonged antibiotic therapy may therefore not be routinely needed if infection is excluded and thorough evaluation for dissemination performed, accompanied by close clinical and biological monitoring. Early transition to oral therapy in this context, which has been implemented in our institution for years, does not appear to be associated with a higher risk of therapeutic failure. These findings align with the most recent literature on the subject.https://journals.asm.org/doi/10.1128/spectrum.03337-24Staphylocococcus aureusprosthesisdeviceoral stepdown therapyshort-course antibiotic therapy |
| spellingShingle | Damien Blez Luc Labarbe Patrick Grohs Jean-Luc Mainardi Jean-Philippe Barnier David Lebeaux Marie Dubert Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study Microbiology Spectrum Staphylocococcus aureus prosthesis device oral stepdown therapy short-course antibiotic therapy |
| title | Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study |
| title_full | Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study |
| title_fullStr | Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study |
| title_full_unstemmed | Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study |
| title_short | Impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated Staphylococcus aureus bacteremia treated with 14 days of antibiotics: a retrospective cohort study |
| title_sort | impact of the presence of a prosthetic implant and transition to oral stepdown therapy on relapse rates and mortality in uncomplicated staphylococcus aureus bacteremia treated with 14 days of antibiotics a retrospective cohort study |
| topic | Staphylocococcus aureus prosthesis device oral stepdown therapy short-course antibiotic therapy |
| url | https://journals.asm.org/doi/10.1128/spectrum.03337-24 |
| work_keys_str_mv | AT damienblez impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT luclabarbe impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT patrickgrohs impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT jeanlucmainardi impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT jeanphilippebarnier impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT davidlebeaux impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy AT mariedubert impactofthepresenceofaprostheticimplantandtransitiontooralstepdowntherapyonrelapseratesandmortalityinuncomplicatedstaphylococcusaureusbacteremiatreatedwith14daysofantibioticsaretrospectivecohortstudy |